Concepedia

Author

Teerha Piratvisuth

Prince of Songkla UniversityORCID

Also Known As

Afdhal, Nezam, Piratvisuth, Teerha, Pisit Tangkijvanich, Suthat Liangpunsakul, T PIRATVISUTH, T Piratvisuth, T. Piratvisuth, TEERHA PIRATVISUTH, Teerha Piratvisuth

233

Publications

14.6K

Citations

41

H-Index

61

Concepts

All Affiliations

Prince of Songkla UniversitySongklanagarind HospitalChinese University of Hong KongUniversity of Hong KongSiriraj Hospital
TP

About

Teerha Piratvisuth is an author at Prince of Songkla University specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

27

5.6K

2

Public Health

6

6

3.6K

3

Epidemiology

6

6

3.7K

4

Health Sciences

1

1

20

5

Gastroenterology

1

1

14

Teerha Piratvisuth

×

83

Publications

12.5K

Citations

36

H-Index

YearCitations

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

Shiv Kumar Sarin, Manoj Kumar, George Lau,

Hepatology International

2015

2.5K

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

George Lau, Teerha Piratvisuth, Kang Luo,

New England Journal of Medicine

2005

1.5K

Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

Patrick Marcellin, George Lau, Ferruccio Bonino,

New England Journal of Medicine

2004

1.1K

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

Yun‐Fan Liaw, Jia‐Horng Kao, Teerha Piratvisuth,

Hepatology International

2012

1K

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

Yun‐Fan Liaw, Nancy Leung, Jia‐Horng Kao,

Hepatology International

2008

869

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B # †

Maurizia Rossana Brunetto, F. Moriconi, Ferruccio Bonino,

Hepatology

2008

481

Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B

W. G. E. Cooksley, Teerha Piratvisuth, Shin‐Da Lee,

Journal of Viral Hepatitis

2003

476

Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa

Erik H.C.J. Buster, Bettina E. Hansen, George Lau,

Gastroenterology

2009

391

Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a

Patrick Marcellin, Ferruccio Bonino, George Lau,

Gastroenterology

2009

313

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Shiv Kumar Sarin, Ashok Choudhury, George Lau,

Hepatology International

2020

293

Page 1